Venturis Therapeutics, Inc is a clinical stage bio-pharmaceutical company
advancing novel therapeutics utilizing regenerative medicine to address
diseases such as diabetic foot ulcers (DFU), severe ischemic heart disease,
and peripheral artery disease (PAD) by regrowing the microvascular
circulation (angiogenesis)
Company Details
- Employees
- 2
- Founded
- -
- Address
- 2626 Cole Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Representative jobs.
- HQ
- Dallas, Texas
Venturis Therapeutics, Inc. Questions
Venturis Therapeutics, Inc.'s website is http://www.venturistherapeutics.com
Venturis Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/venturis-therapeutics-inc
Venturis Therapeutics, Inc. has
2 employees.
View email and phone details for 2
employees at Venturis Therapeutics, Inc..
Venturis Therapeutics, Inc.'s industry is
Biotechnology Research
Venturis Therapeutics, Inc.'s top competitors are
Lantern Pharma Inc. (Nasdaq: Ltrn),
Immunesensor Therapeutics,
Taysha Gene Therapies,
Ventus Therapeutics,
Nanoscope Therapeutics Inc.,
Trivtech Dx,
Venturis Therapeutics,
Biolum Sciences,
Arog Pharmaceuticals, Inc.,
Re-Gen Active Lab.
Venturis Therapeutics, Inc.'s categories are Biotechnology Research
Venturis Therapeutics, Inc.'s founding year is 1999
